To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SMARCA4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
562 representative clones for gene SMARCA4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001128844.1   .a 1 to 5775 1 to 5775 exact RefSeq,   5775/5779
(99 %)
5 diff
(100.0 %id)
AK290033 hippocampus .a 80 to 5576 1 to 5497   tiling clone,   5497/5497
(100 %)
0 diff
(100 %id)
TI_1971554101   .a 324 to 1354 77 to 1105       1029/1107
(92 %)
13 diff
(98.9 %id)
BQ063278 lymph, lymphoma, cell line .a 364 to 1184 1 to 829       829/1070
(77 %)
16 diff
(98.6 %id)
BQ058301 lymph, lymphoma, cell line .a 371 to 1136 15 to 789       775/1097
(70 %)
26 diff
(97.7 %id)
BQ064786 lymph, lymphoma, cell line .a 376 to 1170 19 to 825       807/1070
(75 %)
30 diff
(97.2 %id)
AW246360 lung, small cell carcinoma .a 411 to 947 10 to 547       538/547
(98 %)
1 diff
(99.9 %id)
BX392006   .a 524 to 1411 876 to 1       878/876
(100 %)
29 diff
(96.7 %id)
BQ953285 eye, normal pigmented retinal epithelium .a 526 to 1393 1 to 881       881/931
(94 %)
16 diff
(98.3 %id)
CN386697 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 529 to 1239 1 to 712       712/712
(100 %)
2 diff
(99.8 %id)
BQ064057 lymph, lymphoma, cell line .a 587 to 1403 1 to 828       828/1104
(75 %)
32 diff
(97.2 %id)
BP323740 Pancreas .a 639 to 1221 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BU190184 melanotic melanoma, cell line, skin .a 698 to 1580 1 to 891       891/891
(100 %)
16 diff
(98.3 %id)
BQ062148 lymph, lymphoma, cell line .a 713 to 1608 1 to 906       906/1057
(85 %)
23 diff
(97.9 %id)
CA394248 eye, RPE/choroid .a 798 to 1267 1 to 470       470/470
(100 %)
0 diff
(100 %id)
AW245916 lung, small cell carcinoma .a 894 to 1535 10 to 652       643/652
(98 %)
6 diff
(99.1 %id)
DA722844   .a 966 to 1524 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BQ643473 lymph, lymphoma, cell line .a 997 to 1786 1 to 791   AAA   791/917
(86 %)
16 diff
(98.3 %id)
DA107998 cerebellum .a 1017 to 1571 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AL560609 B cells from Burkitt lymphoma .a 1221 to 2049 830 to 1       830/931
(89 %)
11 diff
(98.9 %id)
CN386673 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1256 to 2045 1 to 790       790/790
(100 %)
1 diff
(99.9 %id)
BE622857 melanotic melanoma, skin .a 1271 to 2056 841 to 60       782/843
(92 %)
8 diff
(99.1 %id)
TI_1971557313   .a 1310 to 2112 1033 to 235       799/1227
(65 %)
13 diff
(99.0 %id)
BU616498 Bone, Subchondral Bone .a 1373 to 2106 750 to 19   AAA   732/732
(100 %)
2 diff
(99.8 %id)
TI_149289437   .a 1396 to 2097 792 to 91   AAA   702/702
(100 %)
2 diff
(99.8 %id)
BU681602 lung .a 1417 to 2097 697 to 17   AAA   681/681
(100 %)
2 diff
(99.8 %id)
BQ000074 Fibrosarcoma .a 1459 to 2114 654 to 1       654/654
(100 %)
5 diff
(99.3 %id)
CA309718 Alveolar Macrophage, lung .a 1461 to 2106 660 to 16   AAA   645/645
(100 %)
2 diff
(99.7 %id)
BE220823 carcinoid, lung .a 1465 to 2098 634 to 1       634/634
(100 %)
2 diff
(99.7 %id)
CN386691 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1467 to 2091 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
DA118936 cerebellum .a 1515 to 2046 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
BQ182922 Knee, Osteoarthritic Cartilage .a 1522 to 2106 600 to 16   AAA   585/585
(100 %)
0 diff
(100 %id)
DB063958 testis .a 1526 to 2095 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
AI952980 anaplastic oligodendroglioma, brain .a 1535 to 2103 570 to 1       570/579
(98 %)
1 diff
(99.9 %id)
AW245658 lung, small cell carcinoma .a 1564 to 2105 544 to 3       542/544
(99 %)
3 diff
(99.5 %id)
TI_153990200   .a 1567 to 2103 641 to 105   AAA   537/537
(100 %)
3 diff
(99.5 %id)
AW246573 lung, small cell carcinoma .a 1590 to 2106 527 to 11   AAA   517/517
(100 %)
2 diff
(99.7 %id)
BQ942014 sciatic nerve .a 1617 to 2461 11 to 860       850/914
(92 %)
27 diff
(97.1 %id)
CX758099 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1622 to 2333 1 to 709     Submitted on the opposite strand 709/827
(85 %)
2 diff
(99.8 %id)
EC482227 Prostate .a 1625 to 1694 70 to 1       70/78
(89 %)
3 diff
(96.2 %id)
BY796625 eye .a 1640 to 2096 1 to 457       457/457
(100 %)
0 diff
(100 %id)
CT003872 T-Lymphocytes .a 1678 to 2444 1 to 770       770/771
(99 %)
8 diff
(99.0 %id)
BG011231 placenta_normal .a 1747 to 1901 162 to 8       155/163
(95 %)
1 diff
(99.4 %id)
BG941197 blood .a 1777 to 2097 354 to 34   AAA   321/326
(98 %)
2 diff
(99.4 %id)
DA314164 hippocampus .a 1789 to 2232 2 to 445   capped   444/444
(100 %)
0 diff
(100 %id)
DA800868 brain .a 1839 to 2392 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CN386693 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1856 to 2630 13 to 786       774/786
(98 %)
6 diff
(99.3 %id)
TI_1971557311   .a 1901 to 2710 824 to 16       809/1308
(61 %)
2 diff
(99.9 %id)
BQ063036 lymph, lymphoma, cell line .a 1909 to 2798 1 to 890       890/1027
(86 %)
8 diff
(99.3 %id)
BM465215 eye, retinoblastoma .a 1971 to 2746 1 to 793       793/1016
(78 %)
23 diff
(97.8 %id)
DA723037   .a 2082 to 2639 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BU192296 embryonal carcinoma, cell line, testis .a 2090 to 2428 340 to 1     Submitted on the opposite strand 340/340
(100 %)
2 diff
(99.5 %id)
BQ277639 ovary, teratocarcinoma, cell line .a 2093 to 2973 1 to 889       889/1067
(83 %)
15 diff
(98.6 %id)
BU556910 ovary, teratocarcinoma, cell line .a 2093 to 2976 1 to 893       893/954
(93 %)
26 diff
(97.3 %id)
TI_1971556635   .a 2123 to 3185 1068 to 9       1060/1296
(81 %)
6 diff
(99.6 %id)
AA312809   .a 2127 to 2351 1 to 225       225/225
(100 %)
0 diff
(100 %id)
BP286776 lung .a 2128 to 2709 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DB292883   .a 2128 to 2777 2 to 650   capped   649/649
(100 %)
7 diff
(99.0 %id)
BQ055650 lymph, lymphoma, cell line .a 2131 to 2960 1 to 837       837/1047
(79 %)
21 diff
(98.0 %id)
CN386681 embryonic stem cells, DMSO-treated H9 cellline .a 2138 to 2700 1 to 563       563/563
(100 %)
0 diff
(100 %id)
BE513612 Burkitt lymphoma, lymph .a 2139 to 2741 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BE561041 Burkitt lymphoma, lymph .a 2139 to 2954 1 to 812       812/1060
(76 %)
32 diff
(97.0 %id)
AA375910 lung .a 2143 to 2351 1 to 209       209/209
(100 %)
0 diff
(100 %id)
DB147535 thymus .a 2148 to 2713 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BQ055497 lymph, lymphoma, cell line .a 2189 to 3056 13 to 883       871/1015
(85 %)
13 diff
(98.8 %id)
CN386676 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2256 to 2997 1 to 743       743/743
(100 %)
1 diff
(99.9 %id)
BQ347310 head_neck .a 2271 to 2866 598 to 3       596/598
(99 %)
3 diff
(99.5 %id)
BM479476 embryonal carcinoma, cell line, testis .a 2287 to 3176 1 to 909       906/1088
(83 %)
29 diff
(97.4 %id)
DB293008   .a 2292 to 3038 2 to 749   capped   748/755
(99 %)
2 diff
(99.8 %id)
BU188479 melanotic melanoma, skin .a 2299 to 3130 1 to 836       836/900
(92 %)
9 diff
(99.0 %id)
BU176729 eye, retinoblastoma .a 2311 to 3174 1 to 871       871/880
(98 %)
10 diff
(98.9 %id)
DA554238   .a 2326 to 2871 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
CN386700 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2345 to 3082 1 to 738       738/738
(100 %)
0 diff
(100 %id)
AL045165 testis .a 2347 to 2958 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BU195199 eye, retinoblastoma .a 2349 to 3224 1 to 882       882/936
(94 %)
26 diff
(97.3 %id)
CN386682 embryonic stem cells, cell lines H1, H7, andH9 .a 2355 to 3118 2 to 765       764/765
(99 %)
0 diff
(100 %id)
TI_1971556613   .a 2404 to 3576 1183 to 18       1170/1289
(90 %)
12 diff
(99.1 %id)
BF204855 muscle, rhabdomyosarcoma .a 2423 to 3223 1 to 793       793/808
(98 %)
24 diff
(97.1 %id)
DA725977   .a 2423 to 2989 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BX342302   .a 2444 to 3304 1 to 861       861/861
(100 %)
0 diff
(100 %id)
BF849977 lung_normal .a 2466 to 2630 180 to 15     Submitted on the opposite strand 164/180
(91 %)
0 diff
(100 %id)
DA305162 hippocampus .a 2491 to 3078 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DB077222 testis .a 2491 to 3060 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA723880   .a 2494 to 3066 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA413375 thalamus .a 2496 to 3044 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA807348 brain .a 2512 to 3069 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA049357   .a 2514 to 3093 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CN386675 embryonic stem cells, cell lines H1, H7, andH9 .a 2526 to 3157 1 to 632       632/632
(100 %)
1 diff
(99.9 %id)
BU190357 melanotic melanoma, cell line, skin .a 2532 to 3422 1 to 894       892/894
(99 %)
14 diff
(98.5 %id)
BQ893319 melanotic melanoma, cell line, skin .a 2532 to 3336 1 to 823       823/920
(89 %)
25 diff
(97.3 %id)
BQ684692 melanotic melanoma, cell line, skin .a 2532 to 3309 1 to 794       794/895
(88 %)
17 diff
(98.2 %id)
BQ676513 melanotic melanoma, cell line, skin .a 2532 to 3388 1 to 867       865/870
(99 %)
18 diff
(98.0 %id)
BQ677319 melanotic melanoma, cell line, skin .a 2532 to 3332 1 to 806       806/916
(87 %)
11 diff
(98.8 %id)
BQ676402 melanotic melanoma, cell line, skin .a 2532 to 3341 1 to 813       813/947
(85 %)
13 diff
(98.7 %id)
BQ679802 melanotic melanoma, cell line, skin .a 2532 to 3332 1 to 812       812/892
(91 %)
17 diff
(98.1 %id)
BQ684409 melanotic melanoma, cell line, skin .a 2532 to 3442 1 to 914       914/929
(98 %)
20 diff
(97.9 %id)
BI918578 brain .a 2543 to 3384 1 to 853       853/853
(100 %)
17 diff
(98.1 %id)
TI_57238444   .a 2543 to 3384 1 to 853       853/853
(100 %)
17 diff
(98.1 %id)
BE894368 melanotic melanoma, skin .a 2545 to 3296 1 to 752       752/792
(94 %)
11 diff
(98.7 %id)
DA454391 tongue, tumor tissue .a 2567 to 3140 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA125863 cerebellum .a 2578 to 3157 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
AW500644 lymph .a 2578 to 3086 7 to 515       509/515
(98 %)
0 diff
(100 %id)
CX786723 human embryonic stem cells .a 2579 to 3423 1 to 845       845/845
(100 %)
1 diff
(99.9 %id)
DA789483 brain .a 2581 to 3166 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DB143226 thymus .a 2581 to 3106 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
BQ422061 embryonal carcinoma, cell line, testis .a 2595 to 3442 1 to 852       852/891
(95 %)
18 diff
(98.0 %id)
DB160581 thymus .a 2599 to 3114 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
AK299761 brain .a 2619 to 5408 1 to 2790       2790/2790
(100 %)
1 diff
(100.0 %id)
DA797196 brain .a 2620 to 3186 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA574687   .a 2638 to 3214 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BQ316513 colon .a 2667 to 3279 612 to 1       612/612
(100 %)
4 diff
(99.4 %id)
CV570889 cornea, eye .a 2676 to 3292 1 to 617       617/617
(100 %)
0 diff
(100 %id)
CF243039 Brain glioblastoma .a 2732 to 3568 1 to 842       840/843
(99 %)
5 diff
(99.5 %id)
CF138885 lymph .a 2801 to 3255 8 to 462       455/462
(98 %)
0 diff
(100 %id)
DB195315 trachea .a 2823 to 3330 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
BM459314 lymph, lymphoma, cell line .a 2871 to 3743 13 to 893       881/1027
(85 %)
20 diff
(98.1 %id)
BI768577 pooled lung and spleen .a 2873 to 3714 1 to 850       850/995
(85 %)
27 diff
(97.3 %id)
TI_57181072   .a 2873 to 3714 30 to 879       850/1024
(83 %)
33 diff
(96.8 %id)
BF796633 lymph, lymphoma, cell line .a 2898 to 3576 1 to 678       678/1179
(57 %)
2 diff
(99.9 %id)
CA488278   .a 2934 to 3798 1 to 876       876/888
(98 %)
15 diff
(98.4 %id)
BP235395 coronary artery .a 2937 to 3518 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA901819   .a 2938 to 3424 2 to 488   capped   487/487
(100 %)
0 diff
(100 %id)
DA499824 brain .a 2945 to 3495 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BX334405 Placenta Cot 25-normalized .a 2947 to 3997 1 to 1043       1043/1122
(92 %)
18 diff
(98.4 %id)
DA778553 brain .a 2950 to 3531 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BM926971 brain .a 2954 to 3882 1 to 940       940/999
(94 %)
18 diff
(98.2 %id)
BM800111 leiomyosarcoma, uterus .a 2963 to 3871 1 to 911       911/1027
(88 %)
14 diff
(98.7 %id)
DB117782 thymus .a 2971 to 3530 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BM804147 eye, retinoblastoma .a 2979 to 3840 1 to 864       864/1092
(79 %)
8 diff
(99.3 %id)
CX760385 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2981 to 3722 1 to 734     Submitted on the opposite strand 734/825
(88 %)
12 diff
(98.6 %id)
BX356713 Placenta Cot 25-normalized .a 2983 to 3997 1 to 1010       1010/1128
(89 %)
10 diff
(99.2 %id)
BE252756 eye, retinoblastoma .a 2985 to 3664 1 to 679       679/680
(99 %)
4 diff
(99.5 %id)
DA742327   .a 2992 to 3513 2 to 523   capped   522/522
(100 %)
0 diff
(100 %id)
DA813829   .a 2999 to 3556 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BX416179 neuroblastoma .a 3012 to 4065 3 to 1045       1043/1085
(96 %)
21 diff
(98.1 %id)
BQ214607 melanotic melanoma, skin .a 3036 to 3889 12 to 872       861/889
(96 %)
46 diff
(94.9 %id)
CX752461 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3038 to 3736 1 to 692     Submitted on the opposite strand 692/835
(82 %)
8 diff
(99.1 %id)
CN386690 embryonic stem cells, DMSO-treated H9 cellline .a 3042 to 3618 1 to 577       577/577
(100 %)
0 diff
(100 %id)
BX436954 thymus .a 3042 to 3704 1 to 663       663/663
(100 %)
0 diff
(100 %id)
BE263693 lung, small cell carcinoma .a 3043 to 3698 1 to 651       651/653
(99 %)
6 diff
(99.1 %id)
CX755267 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3072 to 3850 1 to 774     Submitted on the opposite strand 774/816
(94 %)
7 diff
(99.2 %id)
BM453302 melanotic melanoma, skin .a 3108 to 3910 13 to 824       810/943
(85 %)
22 diff
(97.7 %id)
DA739742   .a 3109 to 3656 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA022931   .a 3114 to 3679 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA738240   .a 3135 to 3882 2 to 749   capped   748/782
(95 %)
6 diff
(99.3 %id)
DA905463   .a 3154 to 3721 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
CX784303 human embryonic stem cells .a 3171 to 3842 1 to 672       672/672
(100 %)
0 diff
(100 %id)
BG286994 bladder, transitional cell papilloma, cell line .a 3191 to 3963 1 to 783       783/1048
(74 %)
19 diff
(98.2 %id)
AU131551   .a 3200 to 3897 2 to 699   capped   698/701
(99 %)
2 diff
(99.8 %id)
DB023054 testis .a 3221 to 3733 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
DR155367 human embryonic stem cells differentiated toan early endodermal cell type .a 3231 to 4036 1 to 806       806/806
(100 %)
3 diff
(99.7 %id)
BG752424 eye, normal pigmented retinal epithelium .a 3234 to 4084 1 to 853       853/853
(100 %)
2 diff
(99.8 %id)
BG752715 eye, normal pigmented retinal epithelium .a 3234 to 4027 1 to 795       795/795
(100 %)
1 diff
(99.9 %id)
DA526535 brain .a 3241 to 3800 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BM709151 eye, RPE and Choroid .a 3259 to 3394 1 to 136       136/136
(100 %)
0 diff
(100 %id)
CA488017   .a 3265 to 4139 1 to 882       882/895
(98 %)
18 diff
(98.0 %id)
CV814863 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3284 to 4119 1 to 842       842/890
(94 %)
36 diff
(96.0 %id)
BE905851 epithelioid carcinoma, Pancreas .a 3321 to 4028 1 to 706       706/706
(100 %)
8 diff
(98.9 %id)
DA305924 hippocampus .a 3359 to 3955 2 to 598   capped   597/597
(100 %)
0 diff
(100 %id)
DA665329   .a 3360 to 3733 2 to 375   capped   374/374
(100 %)
0 diff
(100 %id)
DA685082   .a 3391 to 3926 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA484077 brain .a 3484 to 4040 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA713822   .a 3517 to 4040 2 to 525   capped   524/524
(100 %)
0 diff
(100 %id)
DA714518   .a 3519 to 4068 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA026698   .a 3524 to 4105 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
DA025154   .a 3547 to 4111 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
D56310   .a 3628 to 3960 1 to 333       333/333
(100 %)
0 diff
(100 %id)
DA070177 cerebellum .a 3731 to 4301 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
AW402893 lymph .a 3755 to 4037 1 to 283       283/283
(100 %)
0 diff
(100 %id)
BU557080 ovary, teratocarcinoma, cell line .a 3765 to 4690 1 to 928       928/928
(100 %)
21 diff
(97.8 %id)
BM720550 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4003 to 4436 1 to 434       434/434
(100 %)
0 diff
(100 %id)
BG993099 head_neck .a 4232 to 4472 255 to 6       250/286
(87 %)
8 diff
(97.3 %id)
BE793794 lung, small cell carcinoma .a 4255 to 4504 1 to 250       250/250
(100 %)
0 diff
(100 %id)
BQ671148 epidermoid carcinoma, cell line, salivary gland .a 4289 to 5096 1 to 807       807/928
(86 %)
9 diff
(99.1 %id)
BQ939951 eye, normal pigmented retinal epithelium .a 4297 to 5114 1 to 821       821/972
(84 %)
15 diff
(98.5 %id)
BF064165 colon, colon tumor, RER+ .a 4400 to 4666 267 to 1       267/267
(100 %)
0 diff
(100 %id)
BG474411 eye, retinoblastoma .a 4419 to 4524 1 to 106       106/106
(100 %)
0 diff
(100 %id)
CU443536 epidermis .a 4429 to 4743 333 to 19     Submitted on the opposite strand 315/339
(92 %)
4 diff
(98.9 %id)
BQ058753 lymph, lymphoma, cell line .a 4441 to 5269 1 to 829       829/1003
(82 %)
6 diff
(99.5 %id)
AA558828 Prostate, prostatic intraepithelial neoplasia - highgrade .a 4525 to 4888 363 to 1       363/363
(100 %)
2 diff
(99.5 %id)
CF140944 CNCAP(3)T-225 cell line, Prostate .a 4554 to 5040 7 to 493       487/493
(98 %)
0 diff
(100 %id)
BF688273 eye, normal pigmented retinal epithelium .a 4586 to 5026 1 to 441   fully sequenced,   441/441
(100 %)
1 diff
(99.8 %id)
CU446698 epidermis .a 4619 to 5095 489 to 12     Submitted on the opposite strand 478/500
(95 %)
6 diff
(98.8 %id)
TI_154132492   .a 4688 to 5230 62 to 604     Submitted on the opposite strand 543/1100
(49 %)
20 diff
(98.2 %id)
TI_151737135   .a 4688 to 5209 72 to 593     Submitted on the opposite strand 522/595
(87 %)
10 diff
(98.4 %id)
AA234744 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4692 to 5049 1 to 358     Submitted on the opposite strand 358/358
(100 %)
0 diff
(100 %id)
AI076086 B-cell, chronic lymphotic leukemia .a 4692 to 5011 1 to 320     Submitted on the opposite strand 320/320
(100 %)
0 diff
(100 %id)
AI863913 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 4692 to 4927 1 to 236     Submitted on the opposite strand 236/236
(100 %)
0 diff
(100 %id)
AI860612 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 4692 to 5187 1 to 496     Submitted on the opposite strand 496/496
(100 %)
0 diff
(100 %id)
AW297337   .a 4693 to 5075 1 to 383     Submitted on the opposite strand 383/383
(100 %)
0 diff
(100 %id)
AW575077 lymph .a 4693 to 5127 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
CU445645 epidermis .a 4708 to 5049 354 to 13     Submitted on the opposite strand 342/356
(96 %)
1 diff
(99.8 %id)
BF115547 fibrotheoma, ovary .a 4710 to 5073 1 to 364     Submitted on the opposite strand 364/364
(100 %)
0 diff
(100 %id)
BQ643752 hepatocellular carcinoma, cell line, Liver .a 4726 to 5552 1 to 836       836/1019
(82 %)
15 diff
(98.6 %id)
BQ653861 hepatocellular carcinoma, cell line, Liver .a 4726 to 5527 1 to 804       804/958
(83 %)
22 diff
(97.8 %id)
TI_149307073   .a 4781 to 5553 860 to 92   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 769/937
(82 %)
11 diff
(98.9 %id)
BU608385 Human Lung Epithelial cells, lung .a 4782 to 5545 780 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 762/763
(99 %)
2 diff
(99.8 %id)
BQ956937 brain, neuroblastoma, cell line .a 4792 to 5712 1 to 925       925/926
(99 %)
19 diff
(98.0 %id)
BU857846 adenocarcinoma, cell line, breast .a 4797 to 5558 1 to 769       769/871
(88 %)
12 diff
(98.7 %id)
CR981925 T-Lymphocytes .a 4811 to 5743 1 to 932       932/937
(99 %)
8 diff
(99.2 %id)
BI260084 cervical carcinoma cell line, cervix .a 4852 to 5189 1 to 338       338/338
(100 %)
0 diff
(100 %id)
AW021061 cochlea, ear .a 4854 to 5026 8 to 180   fully sequenced,   173/180
(96 %)
0 diff
(100 %id)
TI_154141370   .a 4863 to 5335 554 to 82     Submitted on the opposite strand 473/475
(99 %)
4 diff
(99.2 %id)
BM797524 Ascites, stomach .a 4864 to 5041 1 to 178       178/178
(100 %)
0 diff
(100 %id)
BU149976 ductal carcinoma, cell line, Pancreas .a 4880 to 5545 1 to 666   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 666/666
(100 %)
0 diff
(100 %id)
DR423809 eye, Pterygium .a 4905 to 5553 691 to 43   AAA Submitted on the opposite strand 649/649
(100 %)
5 diff
(99.3 %id)
BM979000 lung, Primary Lung Epithelial Cells .a 4910 to 5553 662 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 644/644
(100 %)
0 diff
(100 %id)
BU182040 eye, retinoblastoma .a 4922 to 5765 853 to 9     Submitted on the opposite strand 845/853
(99 %)
3 diff
(99.7 %id)
BI492011 cochlea, ear .a 4965 to 5562 616 to 19   fully sequenced,   598/616
(97 %)
1 diff
(99.9 %id)
BF689062 eye, normal pigmented retinal epithelium .a 4965 to 5398 441 to 4   fully sequenced,   438/441
(99 %)
0 diff
(100 %id)
BM790435 Ascites, stomach .a 4978 to 5545 1 to 568   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 568/568
(100 %)
0 diff
(100 %id)
TI_149290182   .a 4991 to 5757 849 to 85   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 765/811
(94 %)
15 diff
(98.2 %id)
BE901358 choriocarcinoma, placenta .a 5020 to 5749 1 to 728       728/728
(100 %)
2 diff
(99.8 %id)
TI_154164839   .a 5029 to 5757 850 to 132   AAA Submitted on the opposite strand 719/849
(84 %)
10 diff
(98.9 %id)
CF136039 lymph .a 5038 to 5757 773 to 63   AAA Submitted on the opposite strand 711/715
(99 %)
12 diff
(98.4 %id)
DR156708 human embryonic stem cells differentiated toan early endodermal cell type .a 5052 to 5764 743 to 31   AAA Submitted on the opposite strand 713/713
(100 %)
0 diff
(100 %id)
BM696906 eye, lens .a 5058 to 5414 1 to 357   fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
BM796815 Ascites, stomach .a 5060 to 5558 1 to 499   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 499/499
(100 %)
0 diff
(100 %id)
BG108369 Bone, osteosarcoma, cell line .a 5082 to 5757 1 to 676   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 676/676
(100 %)
0 diff
(100 %id)
BQ009905 Chondrosarcoma, Left Pubic Bone .a 5086 to 5764 697 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 679/679
(100 %)
0 diff
(100 %id)
BE884265 leiomyosarcoma, uterus .a 5089 to 5169 1 to 81       81/81
(100 %)
0 diff
(100 %id)
BI117829 lung, small cell carcinoma .a 5094 to 5754 1 to 661   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 661/661
(100 %)
0 diff
(100 %id)
BU617296 Bone, Subchondral Bone .a 5105 to 5764 678 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 660/660
(100 %)
0 diff
(100 %id)
BQ009907 Chondrosarcoma, Left Pubic Bone .a 5121 to 5764 662 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 644/644
(100 %)
1 diff
(99.9 %id)
TI_154168642   .a 5122 to 5764 752 to 110   AAA Submitted on the opposite strand 643/762
(84 %)
14 diff
(98.2 %id)
EC490229 Prostate .a 5125 to 5235 1 to 111       111/111
(100 %)
0 diff
(100 %id)
TI_154152813   .a 5129 to 5765 714 to 85     Submitted on the opposite strand 630/658
(95 %)
21 diff
(96.9 %id)
TI_154164142   .a 5129 to 5752 737 to 115   AAA Submitted on the opposite strand 623/844
(73 %)
5 diff
(99.5 %id)
TI_154154293   .a 5130 to 5756 725 to 101   AAA Submitted on the opposite strand 625/637
(98 %)
33 diff
(94.9 %id)
CN347184 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5137 to 5747 1 to 611       611/611
(100 %)
0 diff
(100 %id)
TI_154165275   .a 5137 to 5757 728 to 103   AAA Submitted on the opposite strand 626/812
(77 %)
30 diff
(96.4 %id)
AA480079 ovarian tumor, ovary .a 5164 to 5759 595 to 1     Submitted on the opposite strand 595/595
(100 %)
9 diff
(98.5 %id)
BM693059 eye, Retina Foveal and Macular .a 5181 to 5555 1 to 375   fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 375/375
(100 %)
2 diff
(99.5 %id)
TI_154139225   .a 5186 to 5757 672 to 99   AAA Submitted on the opposite strand 574/575
(99 %)
9 diff
(98.5 %id)
BM973291 lung .a 5206 to 5757 567 to 16   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 552/552
(100 %)
0 diff
(100 %id)
DB382817   .a 5211 to 5550 340 to 1       340/342
(99 %)
3 diff
(99.2 %id)
AI193972 lung .a 5218 to 5765 548 to 1       548/548
(100 %)
0 diff
(100 %id)
BF663247 B-cells, primary B-cells from tonsils (cell line) .a 5224 to 5757 1 to 534   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 534/534
(100 %)
0 diff
(100 %id)
CF138622 lymph .a 5227 to 5764 559 to 22   AAA Submitted on the opposite strand 538/538
(100 %)
0 diff
(100 %id)
BP393575 pancreatic islet .a 5256 to 5757 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
TI_154152815   .a 5267 to 5773 584 to 75     Submitted on the opposite strand 510/727
(70 %)
0 diff
(100 %id)
DB382944   .a 5270 to 5766 500 to 1   tiling clone,   500/542
(92 %)
13 diff
(97.7 %id)
TI_154158956   .a 5272 to 5761 589 to 96   AAA Submitted on the opposite strand 494/629
(78 %)
0 diff
(100 %id)
DB575535 hypothalamus .a 5274 to 5757 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
AA262447 germinal center B cell .a 5277 to 5758 480 to 1     Submitted on the opposite strand 480/480
(100 %)
5 diff
(99.0 %id)
BF930631 nervous_tumor .a 5283 to 5654 372 to 1     Submitted on the opposite strand 372/372
(100 %)
1 diff
(99.8 %id)
AA055417 heart .a 5283 to 5522 241 to 1     Submitted on the opposite strand 241/242
(99 %)
2 diff
(99.2 %id)
TI_151764858   .a 5293 to 5758 100 to 562   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 463/464
(99 %)
6 diff
(98.8 %id)
DB370838   .a 5302 to 5764 465 to 1       465/466
(99 %)
4 diff
(99.2 %id)
BU431022 lymph .a 5320 to 5765 458 to 13     Submitted on the opposite strand 446/458
(97 %)
0 diff
(100 %id)
CF136306 lymph .a 5324 to 5757 464 to 31   AAA Submitted on the opposite strand 434/434
(100 %)
3 diff
(99.4 %id)
AW402767 lymph .a 5343 to 5757 441 to 27   AAA Submitted on the opposite strand 415/415
(100 %)
0 diff
(100 %id)
AW500188 lymph .a 5346 to 5757 441 to 29   AAA Submitted on the opposite strand 413/413
(100 %)
5 diff
(98.8 %id)
W39647 parathyroid gland, parathyroid tumor .a 5349 to 5752 406 to 1     Submitted on the opposite strand 406/406
(100 %)
6 diff
(98.6 %id)
AA402205 ovarian tumor, ovary .a 5362 to 5759 398 to 1     Submitted on the opposite strand 398/398
(100 %)
4 diff
(99.0 %id)
BU735492 eye, lens .a 5384 to 5764 399 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
BU730184 eye, Retina Foveal and Macular .a 5398 to 5553 174 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 156/156
(100 %)
0 diff
(100 %id)
AA010824 heart .a 5400 to 5731 334 to 1     Submitted on the opposite strand 334/334
(100 %)
6 diff
(98.3 %id)
BF054976 pooled .a 5470 to 5757 288 to 1       288/288
(100 %)
0 diff
(100 %id)
AW505557 lymph .a 5498 to 5755 307 to 49   AAA Submitted on the opposite strand 259/261
(99 %)
0 diff
(100 %id)
CF136428 lymph .a 5502 to 5764 298 to 36   AAA Submitted on the opposite strand 263/263
(100 %)
0 diff
(100 %id)
F19689 pectoral muscle (after mastectomy) .a 5542 to 5758 1 to 217       217/217
(100 %)
0 diff
(100 %id)
BM840551 lymph node, stomach .a 5544 to 5764 1 to 221   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 221/221
(100 %)
0 diff
(100 %id)
BM150625 leukopheresis .a 5580 to 5767 203 to 16   tiling clone,   188/206
(91 %)
0 diff
(100 %id)
NM_001128849.1   .b 1 to 5585 1 to 5585 exact RefSeq,   5585/5589
(99 %)
5 diff
(100.0 %id)
AA481374 ovarian tumor, ovary .b 3113 to 3352 1 to 240   tiling clone,   240/244
(98 %)
18 diff
(92.7 %id)
TI_151720985   .b 3786 to 4513 802 to 72   tiling clone,   731/978
(74 %)
8 diff
(99.2 %id)
AA436431 ovarian tumor, ovary .b 3946 to 4476 531 to 1       531/553
(96 %)
27 diff
(95.2 %id)
AA970791 pooled .b 4083 to 4472 388 to 1       388/388
(100 %)
6 diff
(98.5 %id)
BQ222557 large cell carcinoma, lung .c 1 to 463 1 to 462   tiling clone,   462/1208
(38 %)
11 diff
(99.1 %id)
BM541702 leiomyosarcoma, uterus .c 72 to 490 1 to 419       419/1466
(28 %)
9 diff
(99.4 %id)
BE208602 lung, small cell carcinoma .c 85 to 740 1 to 661       661/661
(100 %)
23 diff
(96.6 %id)
DA004213   .c 97 to 624 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA689833   .c 98 to 628 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA704240   .c 98 to 613 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
BM800079 leiomyosarcoma, uterus .c 105 to 613 1 to 510       510/1203
(42 %)
8 diff
(99.4 %id)
EU430759 lung .c 270 to 5114 1 to 4845   tiling clone,   4845/4845
(100 %)
0 diff
(100 %id)
NM_001128847.1   .c 270 to 5585 1 to 5316   RefSeq,   5316/5320
(99 %)
5 diff
(100.0 %id)
AW615543 lung, small cell carcinoma .c 1512 to 2008 497 to 1       497/554
(89 %)
2 diff
(99.7 %id)
AK303352 thymus .c 2586 to 5218 1 to 2633       2633/2633
(100 %)
2 diff
(100.0 %id)
AK026573   .c 2947 to 5355 57 to 2465   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2409/2409
(100 %)
1 diff
(100.0 %id)
TI_1971556629   .c 3129 to 4299 1174 to 8       1167/1288
(90 %)
12 diff
(99.1 %id)
BE249889 adenocarcinoma cell line, colon .c 3384 to 4250 1 to 861       861/864
(99 %)
10 diff
(98.9 %id)
CN347186 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3413 to 4164 1 to 752       752/752
(100 %)
4 diff
(99.5 %id)
BM461999 leiomyosarcoma, uterus .c 3453 to 4266 1 to 815       815/901
(90 %)
10 diff
(98.9 %id)
BG328736 adenocarcinoma cell line, colon .c 3468 to 4244 1 to 768       771/771
(100 %)
16 diff
(98.0 %id)
BG386525 adenocarcinoma cell line, colon .c 3468 to 4226 1 to 764       764/790
(96 %)
24 diff
(97.0 %id)
BF312157 brain, neuroblastoma .c 3507 to 4212 1 to 706       704/707
(99 %)
5 diff
(99.3 %id)
DA636421 Kidney .c 3549 to 4137 2 to 590   capped   589/589
(100 %)
0 diff
(100 %id)
BG821289 adenocarcinoma cell line, colon .c 3557 to 4263 1 to 706       706/706
(100 %)
4 diff
(99.5 %id)
BM781547 Ascites, stomach .c 3559 to 4135 1 to 576       576/576
(100 %)
3 diff
(99.5 %id)
BM781576 Ascites, stomach .c 3559 to 4174 1 to 616       616/616
(100 %)
2 diff
(99.7 %id)
BM931032 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 3580 to 4243 1 to 664       664/668
(99 %)
3 diff
(99.6 %id)
DA693240   .c 3616 to 4184 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
CR989702 T-Lymphocytes .c 3623 to 4328 1 to 703       703/712
(98 %)
8 diff
(98.9 %id)
TI_154172482   .c 3625 to 4259 88 to 723       634/1213
(52 %)
23 diff
(98.2 %id)
CF122446 CNCAP(3)T-225 cell line, Prostate .c 3637 to 4188 2 to 553       552/553
(99 %)
6 diff
(99.0 %id)
TI_154182027   .c 3643 to 4497 73 to 928       856/859
(99 %)
27 diff
(96.9 %id)
TI_151762340   .c 3652 to 4513 910 to 51       860/1005
(85 %)
7 diff
(99.4 %id)
BE395023 endometrium, adenocarcinoma cell line, uterus .c 3663 to 4251 1 to 589       589/590
(99 %)
5 diff
(99.2 %id)
DA008074   .c 3687 to 4220 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
DA490534 brain .c 3698 to 4240 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AI991270 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 3714 to 4489 778 to 1       778/778
(100 %)
10 diff
(98.8 %id)
TI_154137103   .c 3746 to 4513 804 to 42       763/976
(78 %)
12 diff
(98.8 %id)
AA172102   .c 3802 to 4171 1 to 368       368/369
(99 %)
4 diff
(99.0 %id)
AI744900 ovary, tumor, 5 pooled (see description) .c 3805 to 4501 698 to 1       698/762
(91 %)
15 diff
(98.1 %id)
AW007513 anaplastic oligodendroglioma, brain .c 3825 to 4489 665 to 1       665/665
(100 %)
9 diff
(98.7 %id)
BF745029 breast .c 3830 to 4251 425 to 4     Submitted on the opposite strand 422/425
(99 %)
0 diff
(100 %id)
BF975957 B-cells, primary B-cells from tonsils (cell line) .c 3832 to 4334 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
BG754939 B-cells, primary B-cells from tonsils (cell line) .c 3832 to 4334 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
AI885724 anaplastic oligodendroglioma, brain .c 3838 to 4465 628 to 1       628/629
(99 %)
5 diff
(99.3 %id)
AW504911 lymph .c 3876 to 4327 8 to 459       452/459
(98 %)
6 diff
(98.7 %id)
TI_154161318   .c 3876 to 4444 67 to 635       569/569
(100 %)
4 diff
(99.3 %id)
BP298088   .c 3908 to 4487 1 to 580       580/580
(100 %)
0 diff
(100 %id)
AI566971 anaplastic oligodendroglioma, brain .c 3984 to 4476 493 to 1       493/493
(100 %)
3 diff
(99.4 %id)
BF798820 colon_ins .c 3987 to 4403 1 to 417       417/417
(100 %)
0 diff
(100 %id)
CN347188 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3987 to 4261 1 to 275       275/275
(100 %)
0 diff
(100 %id)
TI_154197923   .c 3991 to 4704 77 to 788       712/1056
(67 %)
24 diff
(97.8 %id)
AI299253 2 pooled tumors (clear cell type), Kidney .c 4002 to 4476 475 to 1       475/475
(100 %)
2 diff
(99.6 %id)
AI087403 senescent fibroblast .c 4013 to 4476 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AI923804 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 4017 to 4476 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AA171708   .c 5117 to 5567 452 to 1   tiling clone,   452/452
(100 %)
4 diff
(99.2 %id)
CF994569 Human Placenta, placenta .d 1 to 503 28 to 534   tiling clone,   507/846
(59 %)
30 diff
(96.5 %id)
NM_003072.3   .d 37 to 5735 1 to 5699 exact RefSeq,   5699/5703
(99 %)
5 diff
(100.0 %id)
CT005139 T-Lymphocytes .d 37 to 441 1 to 405       405/408
(99 %)
2 diff
(99.6 %id)
BG396607 eye, retinoblastoma .d 44 to 787 1 to 747       747/749
(99 %)
15 diff
(98.0 %id)
TI_57239045   .d 47 to 799 24 to 776       753/776
(97 %)
10 diff
(98.8 %id)
BI915033 brain .d 55 to 799 1 to 745       745/745
(100 %)
4 diff
(99.5 %id)
AL040328 testis .d 70 to 814 1 to 745       745/745
(100 %)
0 diff
(100 %id)
DB031128 testis .d 86 to 309 2 to 225   capped   224/224
(100 %)
0 diff
(100 %id)
BP206695 coronary artery .d 112 to 695 1 to 584       584/584
(100 %)
3 diff
(99.5 %id)
BP258344 heart .d 112 to 686 1 to 573       574/575
(99 %)
11 diff
(98.1 %id)
BP261971 small intestine .d 114 to 695 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA058355 cerebellum .d 115 to 595 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA378947 thalamus .d 115 to 661 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA379145 thalamus .d 115 to 686 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AU121398 mammary gland .d 115 to 733 2 to 619   capped   618/618
(100 %)
2 diff
(99.7 %id)
BC150298 Clones donated by RIKEN .d 116 to 5505 1 to 5390 exact tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 5390/5390
(100 %)
0 diff
(100 %id)
BP204826 coronary artery .d 116 to 696 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DB444063 testis .d 116 to 560 1 to 444       444/444
(100 %)
8 diff
(98.2 %id)
DB455749 testis .d 116 to 582 1 to 467       467/467
(100 %)
3 diff
(99.4 %id)
BQ439071 embryonal carcinoma, cell line, testis .d 116 to 647 6 to 545       540/1234
(43 %)
26 diff
(97.9 %id)
DA516752 brain .d 117 to 562 2 to 447   capped   446/446
(100 %)
0 diff
(100 %id)
DA584504 lung .d 117 to 707 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
DA936635 Spleen .d 117 to 677 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA960790 Spleen .d 117 to 669 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DB002078 breast, tumor tissue .d 117 to 562 2 to 453   capped   452/452
(100 %)
7 diff
(98.5 %id)
BX374731 Neuroblastoma Cot 25-normalized .d 118 to 1069 1 to 946       946/953
(99 %)
22 diff
(97.7 %id)
BG480871 choriocarcinoma, placenta .d 119 to 677 1 to 560       560/694
(80 %)
11 diff
(98.5 %id)
BG774622 choriocarcinoma, placenta .d 119 to 644 1 to 543       543/893
(60 %)
27 diff
(97.0 %id)
BM461002 leiomyosarcoma, uterus .d 122 to 656 150 to 697       546/1328
(41 %)
30 diff
(97.8 %id)
BF794143 lymph, lymphoma, cell line .d 124 to 891 1 to 767       767/927
(82 %)
15 diff
(98.4 %id)
BG423443 Kidney, renal cell adenocarcinoma .d 131 to 915 1 to 768       768/996
(77 %)
33 diff
(96.7 %id)
BQ930216 leiomyosarcoma, uterus .d 135 to 1021 1 to 900       900/900
(100 %)
46 diff
(94.9 %id)
BE252663 eye, retinoblastoma .d 136 to 738 1 to 618       560/618
(90 %)
12 diff
(98.1 %id)
DB044526 testis .d 137 to 677 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BE731260 choriocarcinoma, placenta .d 139 to 910 1 to 765       765/801
(95 %)
17 diff
(97.9 %id)
CB044610 colon, juvenile granulosa tumor .d 140 to 781 10 to 651       642/651
(98 %)
6 diff
(99.1 %id)
BC139917 Donated clones,Novartis FGA collection .d 148 to 2057 1 to 1910   AAA   1910/1910
(100 %)
1 diff
(100.0 %id)
BC139924 Donated clones,Novartis FGA collection .d 148 to 2057 1 to 1910   AAA   1910/1910
(100 %)
1 diff
(100.0 %id)
DB102323 thymus .d 148 to 514 2 to 368   capped   367/367
(100 %)
1 diff
(99.8 %id)
DA686630   .d 154 to 682 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB007021 cervix, tumor tissue .d 154 to 703 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
AU100034   .d 155 to 454 1 to 300       300/300
(100 %)
9 diff
(97.0 %id)
BQ924423 large cell carcinoma, lung .d 156 to 899 1 to 753       753/929
(81 %)
24 diff
(97.5 %id)
AI879196 brain, frontal lobe .d 157 to 798 1 to 641       641/641
(100 %)
11 diff
(98.3 %id)
AI879201.
matches multiple genes
brain, frontal lobe .d 157 to 749 34 to 626     also hits gene KLF13 593/626
(94 %)
10 diff
(98.5 %id)
DA684939   .d 158 to 703 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
CN386698 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 163 to 797 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BG719422 testis .d 165 to 831 1 to 666       666/667
(99 %)
8 diff
(98.9 %id)
DA591499 lung .d 166 to 736 2 to 573   capped   572/575
(99 %)
2 diff
(99.7 %id)
BG334907 melanotic melanoma, skin .d 166 to 674 1 to 509       509/890
(57 %)
10 diff
(98.9 %id)
CN386699 embryonic stem cells, cell lines H1, H7, andH9 .d 167 to 460 10 to 303       294/303
(97 %)
1 diff
(99.7 %id)
CR612486 Neuroblastoma Cot 25-normalized .d 167 to 2012 1 to 1846       1846/1846
(100 %)
0 diff
(100 %id)
AL525267 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 167 to 1152 1 to 972   fully sequenced,   972/972
(100 %)
13 diff
(98.7 %id)
BG392036 embryonal carcinoma, cell line, testis .d 167 to 911 1 to 772       724/1015
(71 %)
45 diff
(95.6 %id)
BI910797 leukocyte .d 167 to 940 1 to 785       785/785
(100 %)
28 diff
(96.5 %id)
BQ222994 melanotic melanoma, skin .d 167 to 919 1 to 763       763/911
(83 %)
41 diff
(95.5 %id)
TI_57237548   .d 167 to 992 33 to 867       835/909
(91 %)
42 diff
(95.4 %id)
DA540743 lung .d 169 to 728 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
BQ056613 lymph, lymphoma, cell line .d 170 to 676 1 to 507       507/1261
(40 %)
11 diff
(99.2 %id)
BQ642459 lymph, lymphoma, cell line .d 170 to 855 1 to 694       694/1008
(68 %)
28 diff
(97.3 %id)
BQ894571 lymph, lymphoma, cell line .d 170 to 855 1 to 694       694/897
(77 %)
21 diff
(97.7 %id)
DA699954   .d 170 to 562 2 to 394   capped   393/393
(100 %)
2 diff
(99.5 %id)
DB121856 thymus .d 171 to 711 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BU156505 eye, retinoblastoma .d 175 to 638 11 to 474       464/905
(51 %)
7 diff
(99.3 %id)
CR597216 fetal brain .d 176 to 2027 1 to 1852       1852/1852
(100 %)
0 diff
(100 %id)
BE902226 choriocarcinoma, placenta .d 179 to 955 1 to 782       782/950
(82 %)
43 diff
(95.5 %id)
BE727950 melanotic melanoma, skin .d 186 to 909 1 to 741       741/967
(76 %)
34 diff
(96.5 %id)
BG179995 adenocarcinoma, cell line, Prostate .d 189 to 960 1 to 772       772/1156
(66 %)
20 diff
(98.3 %id)
DA420340 cervix .d 190 to 439 2 to 251   capped   250/250
(100 %)
1 diff
(99.6 %id)
CR989315 T-Lymphocytes .d 190 to 677 1 to 489       489/513
(95 %)
4 diff
(99.3 %id)
DB120294 thymus .d 190 to 731 2 to 543   capped   542/542
(100 %)
2 diff
(99.7 %id)
BG258178 embryonal carcinoma, cell line, testis .d 191 to 960 1 to 774       774/953
(81 %)
30 diff
(96.9 %id)
AU133672 ovary, tumor tissue .d 192 to 808 2 to 618   capped   617/619
(99 %)
6 diff
(99.1 %id)
BF797556 lymph, lymphoma, cell line .d 194 to 977 1 to 775       775/1056
(73 %)
33 diff
(96.9 %id)
BM806812 lymph, lymphoma, cell line .d 195 to 855 24 to 686       663/1172
(56 %)
22 diff
(98.2 %id)
BE397899 Burkitt lymphoma, lymph .d 197 to 910 1 to 705       705/715
(98 %)
22 diff
(97.0 %id)
DA000445   .d 201 to 664 2 to 466   capped   465/465
(100 %)
1 diff
(99.8 %id)
BX332967 Neuroblastoma Cot 25-normalized .d 216 to 1110 7 to 900   fully sequenced,   894/900
(99 %)
10 diff
(98.9 %id)
BE867287 adenocarcinoma, colon .d 220 to 725 1 to 515       515/515
(100 %)
16 diff
(96.9 %id)
DB041174 testis .d 221 to 770 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA003028   .d 222 to 788 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA689056   .d 222 to 742 2 to 523   capped   522/522
(100 %)
1 diff
(99.9 %id)
DA690608   .d 222 to 787 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB113269 thymus .d 222 to 799 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
BM818406 stomach .d 224 to 739 1 to 516       516/516
(100 %)
2 diff
(99.7 %id)
BE255408 eye, retinoblastoma .d 233 to 835 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
DA781332 brain .d 239 to 801 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
U29175   .d 243 to 5489 1 to 5247 R569P     5247/5247
(100 %)
7 diff
(99.9 %id)
AW403815 lymph .d 249 to 651 1 to 403       403/404
(99 %)
9 diff
(97.8 %id)
TI_154140705   .d 256 to 833 80 to 657       578/578
(100 %)
24 diff
(95.9 %id)
D26156 brain .d 264 to 5463 1 to 5200 R569P     5200/5200
(100 %)
2 diff
(100.0 %id)
DA848637 placenta .d 265 to 840 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA093465 cerebellum .d 266 to 907 2 to 643   capped   642/642
(100 %)
0 diff
(100 %id)
DB119786 thymus .d 271 to 759 2 to 490   capped   489/489
(100 %)
0 diff
(100 %id)
BX332966 Neuroblastoma Cot 25-normalized .d 1090 to 1561 951 to 489   fully sequenced,   390/878
(44 %)
11 diff
(98.8 %id)
AL525225 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .d 1122 to 2007 888 to 5   fully sequenced,   884/888
(99 %)
8 diff
(99.1 %id)
BX329387 Neuroblastoma Cot 25-normalized .d 1381 to 2056 675 to 1       675/780
(86 %)
7 diff
(99.2 %id)
AU147220 mammary gland .d 1563 to 2066 501 to 1       501/546
(91 %)
12 diff
(97.9 %id)
DB371224 ovary, tumor tissue .d 1579 to 2066 489 to 1       489/491
(99 %)
16 diff
(96.8 %id)
AI879580 brain, frontal lobe .d 1623 to 2071 452 to 4       449/452
(99 %)
0 diff
(100 %id)
CB044609 colon, juvenile granulosa tumor .d 1645 to 2066 440 to 19   AAA   422/422
(100 %)
0 diff
(100 %id)
CD110286 placenta, pre-eclamptic placenta .e 1 to 482 28 to 511   tiling clone,   481/810
(59 %)
19 diff
(97.7 %id)
BQ441179 melanotic melanoma, skin .e 44 to 451 1 to 408       408/1125
(36 %)
15 diff
(98.7 %id)
BU556917 ovary, teratocarcinoma, cell line .e 73 to 539 38 to 504       467/1266
(36 %)
8 diff
(99.4 %id)
BU844907 ovary, teratocarcinoma, cell line .e 101 to 754 1 to 656       656/1082
(60 %)
40 diff
(96.4 %id)
DA080999 cerebellum .e 113 to 549 2 to 438   capped   437/437
(100 %)
3 diff
(99.4 %id)
DA223470 brain .e 113 to 748 2 to 638   capped   637/637
(100 %)
1 diff
(99.9 %id)
DA700096   .e 113 to 559 2 to 448   capped   447/447
(100 %)
0 diff
(100 %id)
DB036955 testis .e 113 to 560 2 to 449   capped   448/448
(100 %)
0 diff
(100 %id)
DB111610 thymus .e 113 to 674 2 to 563   capped   562/572
(98 %)
4 diff
(99.4 %id)
BP205799 coronary artery .e 114 to 674 1 to 562       562/584
(96 %)
9 diff
(98.5 %id)
DB119313 thymus .e 115 to 674 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BG025674 lymph, lymphoma, cell line .e 133 to 752 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
BG818628 anaplastic oligodendroglioma with 1p/19qloss, brain .e 133 to 793 1 to 659       659/659
(100 %)
4 diff
(99.4 %id)
BX404390 neuroblastoma .e 140 to 1046 1 to 907       907/907
(100 %)
4 diff
(99.6 %id)
BP325814 prostata .e 149 to 728 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
DA484918 brain .e 157 to 719 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BG395716 eye, retinoblastoma .e 157 to 864 1 to 723       723/972
(74 %)
16 diff
(98.4 %id)
BC007302 Eye, retinoblastoma .e 158 to 2054 1 to 1895   tiling clone, available from MGC, AAA   1895/1895
(100 %)
1 diff
(100.0 %id)
CN386677 embryonic stem cells, cell lines H1, H7, andH9 .e 161 to 559 1 to 399       399/399
(100 %)
1 diff
(99.8 %id)
CN386671 embryonic stem cells, DMSO-treated H9 cellline .e 164 to 637 1 to 474       474/474
(100 %)
3 diff
(99.4 %id)
BE799077 lung, small cell carcinoma .e 166 to 1022 12 to 867       856/890
(96 %)
21 diff
(97.7 %id)
AL560632 B cells from Burkitt lymphoma .e 167 to 953 1 to 803       803/924
(86 %)
28 diff
(97.0 %id)
BX386771   .e 167 to 642 1 to 467       467/551
(84 %)
10 diff
(98.2 %id)
BQ050150 lymph, lymphoma, cell line .e 167 to 730 1 to 573       571/1463
(39 %)
18 diff
(98.8 %id)
DA685282   .e 171 to 708 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DN999797   .e 178 to 615 20 to 457       438/457
(95 %)
6 diff
(98.7 %id)
BQ055860 lymph, lymphoma, cell line .e 185 to 774 1 to 592       592/1148
(51 %)
8 diff
(99.4 %id)
DB248721 uterus .e 190 to 641 2 to 454   capped   453/453
(100 %)
1 diff
(99.8 %id)
BG424982 Kidney, renal cell adenocarcinoma .e 194 to 908 1 to 724       724/855
(84 %)
26 diff
(97.0 %id)
BC035916.
matches multiple genes
leiomyosarcoma, uterus, Uterus, leiomyosarcoma .e 195 to 2054 12 to 1871   available from MGC, AAA also hits gene pyro 1860/1860
(100 %)
0 diff
(100 %id)
BM803700 leiomyosarcoma, uterus .e 195 to 676 1 to 483       483/1420
(34 %)
5 diff
(99.7 %id)
BE546035 cervical carcinoma cell line, cervix .e 196 to 910 1 to 724       724/842
(85 %)
45 diff
(94.7 %id)
CX872290 embryonic stem .e 197 to 943 1 to 747       747/747
(100 %)
0 diff
(100 %id)
AU134434 ovary, tumor tissue .e 203 to 739 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BG032398 breast, mammary adenocarcinoma, cell line .e 210 to 969 1 to 753       753/1011
(74 %)
11 diff
(99.0 %id)
BX418844 brain, fetal brain .e 216 to 1066 7 to 843       837/852
(98 %)
23 diff
(97.4 %id)
DA614205   .e 222 to 592 2 to 372   capped   371/371
(100 %)
2 diff
(99.5 %id)
DA687937   .e 222 to 758 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA690014   .e 222 to 759 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BE265027 lung, small cell carcinoma .e 223 to 911 1 to 687       687/721
(95 %)
11 diff
(98.5 %id)
BM818638 stomach .e 224 to 406 1 to 186       183/186
(98 %)
1 diff
(99.5 %id)
BF794910 lymph, lymphoma, cell line .e 233 to 939 1 to 709       709/1206
(58 %)
18 diff
(98.6 %id)
BU552820 ovary, teratocarcinoma, cell line .e 261 to 925 24 to 695       672/948
(70 %)
21 diff
(97.8 %id)
BU552780 ovary, teratocarcinoma, cell line .e 267 to 1151 1 to 897       897/899
(99 %)
26 diff
(97.2 %id)
BU849230 ovary, teratocarcinoma, cell line .e 267 to 882 1 to 629       629/888
(70 %)
17 diff
(98.1 %id)
BU849590 ovary, teratocarcinoma, cell line .e 267 to 841 1 to 582       582/749
(77 %)
19 diff
(97.5 %id)
BU854714 ovary, teratocarcinoma, cell line .e 267 to 1078 1 to 819       819/937
(87 %)
15 diff
(98.4 %id)
BU855818 ovary, teratocarcinoma, cell line .e 267 to 1078 1 to 817       817/966
(84 %)
9 diff
(99.1 %id)
BU859109 ovary, teratocarcinoma, cell line .e 267 to 1079 1 to 824       824/943
(87 %)
16 diff
(98.4 %id)
BG777886 adenocarcinoma, Prostate .e 272 to 565 1 to 292       292/292
(100 %)
3 diff
(99.0 %id)
EU430756 lung .e 318 to 5159 1 to 4842 exact tiling clone,   4842/4842
(100 %)
0 diff
(100 %id)
NM_001128848.1   .e 318 to 5630 1 to 5313 exact RefSeq,   5313/5317
(99 %)
5 diff
(100.0 %id)
AU155414 ovary, tumor tissue .e 1648 to 2054 405 to 1       405/410
(98 %)
2 diff
(99.6 %id)
BG744240 blood, natural killer cells, cell line .e 3655 to 4286 1 to 632       632/632
(100 %)
4 diff
(99.4 %id)
BU539419 adenocarcinoma, cell line, breast .e 4036 to 4922 1 to 890       890/891
(99 %)
9 diff
(99.0 %id)
BU957286 adenocarcinoma, cell line, breast .e 4036 to 4747 1 to 714       714/963
(74 %)
5 diff
(99.5 %id)
TI_154196913   .e 4049 to 4895 1 to 845       845/1055
(80 %)
24 diff
(97.8 %id)
TI_154195665   .e 4052 to 4991 1 to 942       940/1079
(87 %)
27 diff
(97.5 %id)
BQ331626 lung_tumor .e 4486 to 4682 28 to 226       199/228
(87 %)
10 diff
(95.7 %id)
AA326726 brain, cerebellum .e 4507 to 4850 1 to 346       346/353
(98 %)
4 diff
(98.9 %id)
BE379236 endometrium, adenocarcinoma cell line, uterus .e 4522 to 5059 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
BM794003 Ascites, stomach .e 4543 to 5188 1 to 646       646/646
(100 %)
1 diff
(99.9 %id)
BF975347 B-cells, primary B-cells from tonsils (cell line) .e 4546 to 5379 1 to 837   tiling clone,   837/1113
(75 %)
34 diff
(97.0 %id)
TI_154132422   .e 4546 to 5222 19 to 699     Submitted on the opposite strand 681/1003
(67 %)
18 diff
(98.3 %id)
TI_154133936   .e 4546 to 5205 56 to 719     Submitted on the opposite strand 664/1102
(60 %)
28 diff
(97.5 %id)
TI_154136480   .e 4546 to 5115 20 to 595     Submitted on the opposite strand 576/1157
(49 %)
33 diff
(97.2 %id)
AA054955 heart .e 4550 to 4938 1 to 392     Submitted on the opposite strand 392/392
(100 %)
3 diff
(99.3 %id)
AA889318   .e 4550 to 5005 1 to 457     Submitted on the opposite strand 457/457
(100 %)
5 diff
(99.0 %id)
AA977691 carcinoid, lung .e 4550 to 5056 1 to 507     Submitted on the opposite strand 507/507
(100 %)
0 diff
(100 %id)
AA989216 carcinoid, lung .e 4550 to 4910 1 to 361     Submitted on the opposite strand 361/361
(100 %)
0 diff
(100 %id)
AI126707 heart .e 4550 to 5049 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
AI189014 placenta .e 4550 to 5000 1 to 451     Submitted on the opposite strand 451/451
(100 %)
0 diff
(100 %id)
AI185603 lung .e 4550 to 4850 1 to 301     Submitted on the opposite strand 301/307
(98 %)
5 diff
(98.4 %id)
AI660360 thymus, pooled .e 4550 to 4932 1 to 383     Submitted on the opposite strand 383/383
(100 %)
0 diff
(100 %id)
AI760002 Kidney .e 4550 to 4941 1 to 392     Submitted on the opposite strand 392/392
(100 %)
1 diff
(99.8 %id)
AI885870 anaplastic oligodendroglioma, brain .e 4550 to 4912 1 to 363     Submitted on the opposite strand 363/363
(100 %)
0 diff
(100 %id)
BF059036 fibrotheoma, ovary .e 4550 to 5012 1 to 463     Submitted on the opposite strand 463/463
(100 %)
4 diff
(99.2 %id)
AW574972 lymph .e 4551 to 4952 1 to 402     Submitted on the opposite strand 402/402
(100 %)
1 diff
(99.8 %id)
AW576243 lymph .e 4551 to 5013 1 to 463     Submitted on the opposite strand 463/463
(100 %)
0 diff
(100 %id)
AW339201 adenocarcinoma, Pancreas .e 4558 to 5090 1 to 526     Submitted on the opposite strand 526/557
(94 %)
23 diff
(95.9 %id)
AI290616 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 4565 to 5065 1 to 504     Submitted on the opposite strand 504/504
(100 %)
14 diff
(97.3 %id)
AI184557   .e 4568 to 4931 1 to 364     Submitted on the opposite strand 364/366
(99 %)
1 diff
(99.8 %id)
AI276460 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 4568 to 5002 1 to 435     Submitted on the opposite strand 435/435
(100 %)
1 diff
(99.8 %id)
AI394530 brain, glioblastoma (pooled) .e 4568 to 5048 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
BG744974 blood, natural killer cells, cell line .e 4580 to 5354 777 to 2   tiling clone,   776/777
(99 %)
0 diff
(100 %id)
AW007209 anaplastic oligodendroglioma, brain .e 4586 to 5156 1 to 571     Submitted on the opposite strand 571/571
(100 %)
1 diff
(99.9 %id)
AA247481   .e 4597 to 4920 1 to 324       324/324
(100 %)
0 diff
(100 %id)
AA479685 ovarian tumor, ovary .e 4607 to 5057 1 to 454     Submitted on the opposite strand 451/454
(99 %)
51 diff
(88.8 %id)
AA807669 germinal center B cell .e 4614 to 5039 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
AA687287 germinal center B cell .e 4616 to 5057 1 to 442     Submitted on the opposite strand 442/442
(100 %)
0 diff
(100 %id)
AA807997 germinal center B cell .e 4616 to 5000 1 to 385     Submitted on the opposite strand 385/385
(100 %)
1 diff
(99.8 %id)
AA731500 germinal center B cell .e 4626 to 5035 1 to 409     Submitted on the opposite strand 409/409
(100 %)
1 diff
(99.8 %id)
AA788842 heart .e 4632 to 4968 1 to 337     Submitted on the opposite strand 337/337
(100 %)
0 diff
(100 %id)
DA695077   .f 1 to 558 8 to 565   tiling clone, capped   564/564
(100 %)
2 diff
(99.7 %id)
AB209313 brain .f 408 to 5599 1 to 5192   tiling clone,   5192/5192
(100 %)
0 diff
(100 %id)
CN347187 embryonic stem cells, DMSO-treated H9 cellline .f 3639 to 4200 8 to 569       562/569
(98 %)
6 diff
(99.0 %id)
DB109223 thymus .f 3649 to 4215 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CN275229 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 3692 to 4338 1 to 648       648/648
(100 %)
1 diff
(99.9 %id)
BI038512 nervous_tumor .f 3824 to 4103 280 to 1       280/280
(100 %)
0 diff
(100 %id)
BI039079 nervous_tumor .f 3824 to 4103 280 to 1       280/280
(100 %)
0 diff
(100 %id)
BI040385 nervous_tumor .f 3824 to 4103 1 to 280       280/280
(100 %)
0 diff
(100 %id)
BM040815 Kidney, Wilms' tumor, cell line .f 3843 to 4634 1 to 793   available from MGC,   793/794
(99 %)
10 diff
(98.8 %id)
BC033232 Kidney, Wilm's tumor .f 3844 to 5599 1 to 1756   available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 1756/1756
(100 %)
0 diff
(100 %id)
TI_154037445   .f 4006 to 4343 396 to 59   AAA   338/807
(41 %)
0 diff
(100 %id)
BX096945 whole brain .f 4156 to 4693 1 to 538       538/538
(100 %)
0 diff
(100 %id)
AA504818 germinal center B cell .f 5210 to 5599 407 to 18   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 390/390
(100 %)
0 diff
(100 %id)
AK055168 tongue, tumor tissue .g 1 to 3376 2 to 3377 exact tiling clone, available from FLJ,   3377/3377
(100 %)
1 diff
(100.0 %id)
DA434121 tongue, tumor tissue .g 1 to 518 2 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DB313280 tongue, tumor tissue .g 2886 to 3376 492 to 1       492/492
(100 %)
5 diff
(99.0 %id)
CF242908 Brain glioblastoma .h 1 to 880 1 to 885   tiling clone,   885/887
(99 %)
13 diff
(98.6 %id)
TI_154134331   .h 284 to 980 764 to 57   tiling clone,   708/911
(77 %)
29 diff
(96.9 %id)
BF772393 epid_tumor .h 341 to 783 1 to 443   tiling clone,   443/443
(100 %)
0 diff
(100 %id)
CN347183 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 389 to 728 1 to 340       340/340
(100 %)
1 diff
(99.8 %id)
DA166176 amygdala .i 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
TI_57167251   .i 20 to 777 16 to 769       754/769
(98 %)
15 diff
(98.1 %id)
BI835516 pooled pancreas and spleen .i 35 to 777 1 to 739   tiling clone,   739/739
(100 %)
8 diff
(99.0 %id)
BP264764 umbilical vein .i 55 to 624 1 to 572       572/572
(100 %)
7 diff
(98.8 %id)
CF137943 lymph .i 108 to 218 2 to 112       111/112
(99 %)
6 diff
(94.7 %id)
TI_154167668   .i 114 to 590 80 to 562       483/490
(98 %)
52 diff
(89.4 %id)
DB056340 testis .i 129 to 701 2 to 575   tiling clone, capped   574/574
(100 %)
3 diff
(99.5 %id)
CN290988 embryonic stem cells, DMSO-treated H9 cellline .i 141 to 244 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BU189349 melanotic melanoma, skin .i 147 to 935 1 to 809 G60X P61A G62W G63R Y64V ... tiling clone,   809/906
(89 %)
28 diff
(97.0 %id)
DB083314 testis .i 148 to 699 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
AA459566 germinal center B cell .j-u 1 to 425 1 to 425   tiling clone, fully sequenced,   425/425
(100 %)
0 diff
(100 %id)
AA873637 germinal center B cell .j-u 99 to 570 473 to 1       473/475
(99 %)
12 diff
(97.5 %id)
AA772023 parathyroid gland, parathyroid tumor .j-u 202 to 661 458 to 1       458/458
(100 %)
2 diff
(99.6 %id)
BE221637 carcinoid, lung .j-u 222 to 661 439 to 1       439/439
(100 %)
5 diff
(98.9 %id)
AA806033 germinal center B cell .j-u 254 to 673 418 to 1       418/418
(100 %)
2 diff
(99.6 %id)
AW149655 brain, medulloblastoma .j-u 255 to 674 419 to 1       419/419
(100 %)
1 diff
(99.8 %id)
TI_157594687   .j-u 257 to 699 489 to 46 E88R Q89A E90R A91S E92R ...     444/702
(63 %)
0 diff
(100 %id)
AW139392   .j-u 258 to 693 436 to 1   tiling clone,   436/447
(97 %)
0 diff
(100 %id)
AI925235 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .j-u 347 to 685 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
AA725055 parathyroid gland, parathyroid tumor .j-u 376 to 657 280 to 1       280/280
(100 %)
3 diff
(99.0 %id)
AA459346 germinal center B cell .j-u 395 to 661 265 to 1   fully sequenced,   265/265
(100 %)
3 diff
(98.9 %id)
DA049097   .k 1 to 465 2 to 466 exact tiling clone, capped   465/465
(100 %)
0 diff
(100 %id)
BG946409 bladder_tumor .l 1 to 480 518 to 33 V3L E10G S12G E16V V36L ... tiling clone,   485/524
(92 %)
6 diff
(98.9 %id)
DA383267 thalamus .m-u 1 to 548 2 to 550   tiling clone, capped   549/549
(100 %)
3 diff
(99.5 %id)
DA160789 amygdala .m-u 351 to 925 2 to 576   tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
BQ709049 Spleen .m-u 737 to 1714 12 to 1001 exact tiling clone,   990/1001
(98 %)
25 diff
(97.6 %id)
BU509585 leiomyosarcoma, uterus .m-u 798 to 1626 1 to 831 exact     831/866
(95 %)
15 diff
(98.3 %id)
AI884327 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 993 to 1549 557 to 1 exact     557/557
(100 %)
0 diff
(100 %id)
BE326243 carcinoid, lung .m-u 1086 to 1548 463 to 1       463/463
(100 %)
2 diff
(99.6 %id)
BE503149 carcinoid, lung .m-u 1087 to 1548 462 to 1       462/462
(100 %)
2 diff
(99.6 %id)
BF893694 marrow .m-u 1168 to 1549 19 to 405       387/405
(95 %)
9 diff
(97.8 %id)
N99416 multiple sclerosis lesions .m-u 1258 to 1423 1 to 166       166/166
(100 %)
0 diff
(100 %id)
AW128846 ovary, tumor, 5 pooled (see description) .m-u 1301 to 1681 447 to 67   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
AW071577 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .m-u 1360 to 1694 337 to 3       335/337
(99 %)
0 diff
(100 %id)
BE395501 endometrium, adenocarcinoma cell line, uterus .m-u 1377 to 2036 1 to 657       657/660
(99 %)
17 diff
(97.5 %id)
DA832184 placenta .m-u 1507 to 2189 2 to 684   tiling clone, capped   683/685
(99 %)
2 diff
(99.8 %id)
BF351114 head_neck .m-u 1877 to 2111 248 to 15       234/248
(94 %)
0 diff
(100 %id)
CB987029 Pooled-Glandular .m-u 1925 to 2534 1 to 623   tiling clone,   623/830
(75 %)
27 diff
(96.8 %id)
N73791 multiple sclerosis lesions .m-u 2065 to 2572 512 to 1   tiling clone,   512/517
(99 %)
29 diff
(94.4 %id)
DB378236 placenta .m-u 2570 to 3081 512 to 1   tiling clone,   512/512
(100 %)
13 diff
(97.5 %id)
CV353554 nervous_normal .n-u 1 to 519 7 to 528 D28* tiling clone,   522/528
(98 %)
6 diff
(98.9 %id)
BE925446 amnion_normal .n-u 333 to 563 22 to 254 S3R R4S L5I P6A C7V ... tiling clone,   233/256
(91 %)
5 diff
(98.1 %id)
DB139028 thymus .o 1 to 551 2 to 551 L82G G83R A84C A85S Q86T ... tiling clone, capped   550/550
(100 %)
2 diff
(99.7 %id)
DB196117 trachea .p 1 to 511 2 to 512 exact tiling clone, capped   511/511
(100 %)
1 diff
(99.9 %id)
AK308763 amygdala Gene SMARCA4, variant not shown         This clone was ignored    
BC136644 Testicle, PCR rescued clones Gene SMARCA4, variant not shown         This clone was ignored    
EU430757 lung Gene SMARCA4, variant not shown         This clone was ignored    
EU430758 lung Gene SMARCA4, variant not shown         This clone was ignored    
NM_001128845.1   Gene SMARCA4, variant not shown       RefSeq, This clone was ignored    
NM_001128846.1   Gene SMARCA4, variant not shown       RefSeq, This clone was ignored    
BU616319 Bone, Subchondral Bone Gene SMARCA4, variant not shown       AAA Submitted on the opposite strand    
241 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m-u, .n-u, .o, .p Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI